Proto Script Pharmaceutical Stock Performance
| PSCR Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of -0.86, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Proto Script are expected to decrease slowly. On the other hand, during market turmoil, Proto Script is expected to outperform it slightly. At this point, Proto Script Pharmac has a negative expected return of -1.06%. Please make sure to check Proto Script's treynor ratio and day median price , to decide if Proto Script Pharmac performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Proto Script Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in February 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Proto |
Proto Script Relative Risk vs. Return Landscape
If you would invest 0.03 in Proto Script Pharmaceutical on October 28, 2025 and sell it today you would lose (0.02) from holding Proto Script Pharmaceutical or give up 66.67% of portfolio value over 90 days. Proto Script Pharmaceutical is currently does not generate positive expected returns and assumes 8.3992% risk (volatility on return distribution) over the 90 days horizon. In different words, 75% of pink sheets are less volatile than Proto, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Proto Script Target Price Odds to finish over Current Price
The tendency of Proto Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 83.16 |
Based on a normal probability distribution, the odds of Proto Script to move above the current price in 90 days from now is about 83.16 (This Proto Script Pharmaceutical probability density function shows the probability of Proto Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Proto Script Pharmaceutical has a beta of -0.86 indicating Additionally Proto Script Pharmaceutical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Proto Script Price Density |
| Price |
Predictive Modules for Proto Script
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Proto Script Pharmac. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Proto Script's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Proto Script Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Proto Script is not an exception. The market had few large corrections towards the Proto Script's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Proto Script Pharmaceutical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Proto Script within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.99 | |
β | Beta against Dow Jones | -0.86 | |
σ | Overall volatility | 0.0001 | |
Ir | Information ratio | -0.13 |
Proto Script Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Proto Script for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Proto Script Pharmac can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Proto Script Pharmac generated a negative expected return over the last 90 days | |
| Proto Script Pharmac has high historical volatility and very poor performance | |
| Proto Script Pharmac has some characteristics of a very speculative penny stock | |
| Proto Script Pharmac has a very high chance of going through financial distress in the upcoming years | |
| Proto Script Pharmaceutical currently holds 372.75 K in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Proto Script Pharmac has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Proto Script until it has trouble settling it off, either with new capital or with free cash flow. So, Proto Script's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proto Script Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proto to invest in growth at high rates of return. When we think about Proto Script's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 788.96 K. Net Loss for the year was (7.18 M) with profit before overhead, payroll, taxes, and interest of 564.47 K. |
Proto Script Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Proto Pink Sheet often depends not only on the future outlook of the current and potential Proto Script's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Proto Script's indicators that are reflective of the short sentiment are summarized in the table below.
| Dividends Paid | 59.6 K | |
| Short Long Term Debt | 51.3 K | |
| Shares Float | 44.8 M |
Proto Script Fundamentals Growth
Proto Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Proto Script, and Proto Script fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Proto Pink Sheet performance.
| Return On Asset | -2.41 | |||
| Operating Margin | (1.60) % | |||
| Current Valuation | 464.66 K | |||
| Shares Outstanding | 49.14 M | |||
| Price To Earning | 17.07 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 788.96 K | |||
| EBITDA | (962.57 K) | |||
| Cash And Equivalents | 56.36 K | |||
| Total Debt | 372.75 K | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | 44.1 K | |||
| Earnings Per Share | (0.06) X | |||
| Total Asset | 170.19 K | |||
| Retained Earnings | (186 K) | |||
| Current Asset | 12 K | |||
| Current Liabilities | 89 K | |||
About Proto Script Performance
Assessing Proto Script's fundamental ratios provides investors with valuable insights into Proto Script's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Proto Script is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California. Proto Script operates under Specialty Business Services classification in the United States and is traded on OTC Exchange.Things to note about Proto Script Pharmac performance evaluation
Checking the ongoing alerts about Proto Script for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Proto Script Pharmac help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Proto Script Pharmac generated a negative expected return over the last 90 days | |
| Proto Script Pharmac has high historical volatility and very poor performance | |
| Proto Script Pharmac has some characteristics of a very speculative penny stock | |
| Proto Script Pharmac has a very high chance of going through financial distress in the upcoming years | |
| Proto Script Pharmaceutical currently holds 372.75 K in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Proto Script Pharmac has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Proto Script until it has trouble settling it off, either with new capital or with free cash flow. So, Proto Script's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proto Script Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proto to invest in growth at high rates of return. When we think about Proto Script's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 788.96 K. Net Loss for the year was (7.18 M) with profit before overhead, payroll, taxes, and interest of 564.47 K. |
- Analyzing Proto Script's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Proto Script's stock is overvalued or undervalued compared to its peers.
- Examining Proto Script's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Proto Script's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Proto Script's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Proto Script's pink sheet. These opinions can provide insight into Proto Script's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Proto Pink Sheet Analysis
When running Proto Script's price analysis, check to measure Proto Script's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proto Script is operating at the current time. Most of Proto Script's value examination focuses on studying past and present price action to predict the probability of Proto Script's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proto Script's price. Additionally, you may evaluate how the addition of Proto Script to your portfolios can decrease your overall portfolio volatility.